Viollier A F, Senn H J, Obrecht J P
Schweiz Med Wochenschr. 1978 Dec 9;108(49):1958-61.
102 patients from the same oncologic center with malignant lymphomas (52 with Hodgkin's disease, 50 with non-Hodgkin lymphomas) have been analyzed. One population received monochemotherapy only and the other polychemotherapy: the first remission and survival results were published in 1975 on the basis of calculated life expectancy. Now, 3 years later, the same populations are again analyzed and "real" survival data are compared with those calculated. All patients now have a minimal observation time of 6 years. Even if our first published data were too optimistic, polychemotherapy still appears to offer the better life expectancy.
对来自同一肿瘤中心的102例恶性淋巴瘤患者（52例霍奇金病，50例非霍奇金淋巴瘤）进行了分析。一组仅接受单一化疗，另一组接受联合化疗：首次缓解和生存结果于1975年根据计算出的预期寿命公布。现在，3年后，再次对相同人群进行分析，并将“实际”生存数据与计算数据进行比较。所有患者目前的最短观察时间为6年。即使我们首次公布的数据过于乐观，联合化疗似乎仍能提供更好的预期寿命。
